BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis - Quiz - MDSpire

BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

  • By

  • Thomas Silfverberg

  • Christina Zjukovskaja

  • Yassine Noui

  • Kristina Carlson

  • Joachim Burman

  • August 26, 2024

  • 0 min

Share

Original Source(s)

BEAM or cyclophosphamide in autologous haematopoietic stem cell transplantation for relapsing-remitting multiple sclerosis

  • by Thomas Silfverberg, Christina Zjukovskaja, Yassine Noui, Kristina Carlson, Joachim Burman

  • August 26, 2024

Related Content

Broader anti-EBV TCR repertoire in multiple sclerosis: disease specificity and treatment modulation

Post-streptococcal Autoimmunity and Its Relevance to Epstein–Barr virus as the Potential Cause of Multiple Sclerosis

Hematopoietic stem cell transplantation and cellular therapies for autoimmune diseases: overview and future considerations from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT)